These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 19018247)

  • 1. Type-dependent oxidative damage in frontotemporal lobar degeneration: cortical astrocytes are targets of oxidative damage.
    Martínez A; Carmona M; Portero-Otin M; Naudí A; Pamplona R; Ferrer I
    J Neuropathol Exp Neurol; 2008 Dec; 67(12):1122-36. PubMed ID: 19018247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neuropathology of frontotemporal lobar degeneration with respect to the cytological and biochemical characteristics of tau protein.
    Taniguchi S; McDonagh AM; Pickering-Brown SM; Umeda Y; Iwatsubo T; Hasegawa M; Mann DM
    Neuropathol Appl Neurobiol; 2004 Feb; 30(1):1-18. PubMed ID: 14720172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severity of gliosis in Pick's disease and frontotemporal lobar degeneration: tau-positive glia differentiate these disorders.
    Schofield E; Kersaitis C; Shepherd CE; Kril JJ; Halliday GM
    Brain; 2003 Apr; 126(Pt 4):827-40. PubMed ID: 12615642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival in two variants of tau-negative frontotemporal lobar degeneration: FTLD-U vs FTLD-MND.
    Josephs KA; Knopman DS; Whitwell JL; Boeve BF; Parisi JE; Petersen RC; Dickson DW
    Neurology; 2005 Aug; 65(4):645-7. PubMed ID: 16116138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glial fibrillary acidic protein is a major target of glycoxidative and lipoxidative damage in Pick's disease.
    Muntané G; Dalfó E; Martínez A; Rey MJ; Avila J; Pérez M; Portero M; Pamplona R; Ayala V; Ferrer I
    J Neurochem; 2006 Oct; 99(1):177-85. PubMed ID: 16987245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glial fibrillar acidic protein in the cerebrospinal fluid of Alzheimer's disease, dementia with Lewy bodies, and frontotemporal lobar degeneration.
    Ishiki A; Kamada M; Kawamura Y; Terao C; Shimoda F; Tomita N; Arai H; Furukawa K
    J Neurochem; 2016 Jan; 136(2):258-61. PubMed ID: 26485083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced Tau protein expression is associated with frontotemporal degeneration with progranulin mutation.
    Papegaey A; Eddarkaoui S; Deramecourt V; Fernandez-Gomez FJ; Pantano P; Obriot H; Machala C; Anquetil V; Camuzat A; Brice A; Maurage CA; Le Ber I; Duyckaerts C; Buée L; Sergeant N; Buée-Scherrer V
    Acta Neuropathol Commun; 2016 Jul; 4(1):74. PubMed ID: 27435172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin.
    Mukherjee O; Pastor P; Cairns NJ; Chakraverty S; Kauwe JS; Shears S; Behrens MI; Budde J; Hinrichs AL; Norton J; Levitch D; Taylor-Reinwald L; Gitcho M; Tu PH; Tenenholz Grinberg L; Liscic RM; Armendariz J; Morris JC; Goate AM
    Ann Neurol; 2006 Sep; 60(3):314-22. PubMed ID: 16983685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frontotemporal lobar degeneration with ubiquitin-positive, but TDP-43-negative inclusions.
    Josephs KA; Lin WL; Ahmed Z; Stroh DA; Graff-Radford NR; Dickson DW
    Acta Neuropathol; 2008 Aug; 116(2):159-67. PubMed ID: 18553091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions visualized with ubiquitin-binding protein p62 immunohistochemistry.
    Pikkarainen M; Hartikainen P; Alafuzoff I
    J Neuropathol Exp Neurol; 2008 Apr; 67(4):280-98. PubMed ID: 18379439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitin-positive neuronal and tau 2-positive glial inclusions in frontotemporal dementia of motor neuron type.
    Forno LS; Langston JW; Herrick MK; Wilson JD; Murayama S
    Acta Neuropathol; 2002 Jun; 103(6):599-606. PubMed ID: 12012092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TDP-43-positive white matter pathology in frontotemporal lobar degeneration with ubiquitin-positive inclusions.
    Neumann M; Kwong LK; Truax AC; Vanmassenhove B; Kretzschmar HA; Van Deerlin VM; Clark CM; Grossman M; Miller BL; Trojanowski JQ; Lee VM
    J Neuropathol Exp Neurol; 2007 Mar; 66(3):177-83. PubMed ID: 17356379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White matter lesions in the brain with frontotemporal lobar degeneration with motor neuron disease: TDP-43-immunopositive inclusions co-localize with p62, but not ubiquitin.
    Hiji M; Takahashi T; Fukuba H; Yamashita H; Kohriyama T; Matsumoto M
    Acta Neuropathol; 2008 Aug; 116(2):183-91. PubMed ID: 18584184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression analysis of frontotemporal lobar degeneration of the motor neuron disease type with ubiquitinated inclusions.
    Mishra M; Paunesku T; Woloschak GE; Siddique T; Zhu LJ; Lin S; Greco K; Bigio EH
    Acta Neuropathol; 2007 Jul; 114(1):81-94. PubMed ID: 17569064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquitin immunohistochemistry of frontotemporal lobar degeneration differentiates cases with and without motor neuron disease.
    Katsuse O; Dickson DW
    Alzheimer Dis Assoc Disord; 2005; 19 Suppl 1():S37-43. PubMed ID: 16317257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frontotemporal dementia with co-occurrence of astrocytic plaques and tufted astrocytes, and severe degeneration of the cerebral white matter: a variant of corticobasal degeneration?
    Tan CF; Piao YS; Kakita A; Yamada M; Takano H; Tanaka M; Mano A; Makino K; Nishizawa M; Wakabayashi K; Takahashi H
    Acta Neuropathol; 2005 Mar; 109(3):329-38. PubMed ID: 15841415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathological changes underlying frontotemporal lobar degeneration with clinicopathological correlation.
    Shi J; Shaw CL; Du Plessis D; Richardson AM; Bailey KL; Julien C; Stopford C; Thompson J; Varma A; Craufurd D; Tian J; Pickering-Brown S; Neary D; Snowden JS; Mann DM
    Acta Neuropathol; 2005 Nov; 110(5):501-12. PubMed ID: 16222525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process.
    Togo T; Dickson DW
    Acta Neuropathol; 2002 Oct; 104(4):398-402. PubMed ID: 12200627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical ubiquitin-positive inclusions in frontotemporal dementia without motor neuron disease: a quantitative immunocytochemical study.
    Kövari E; Gold G; Giannakopoulos P; Bouras C
    Acta Neuropathol; 2004 Sep; 108(3):207-12. PubMed ID: 15170577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TDP-43 in ubiquitinated inclusions in the inferior olives in frontotemporal lobar degeneration and in other neurodegenerative diseases: a degenerative process distinct from normal ageing.
    Davidson Y; Amin H; Kelley T; Shi J; Tian J; Kumaran R; Lashley T; Lees AJ; DuPlessis D; Neary D; Snowden J; Akiyama H; Arai T; Hasegawa M; Bandopadhyay R; Sikkink S; Pickering-Brown S; Mann DM
    Acta Neuropathol; 2009 Sep; 118(3):359-69. PubMed ID: 19330339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.